Kite Immunotherapy Drug Helps Blood Cancer Patients in Study Kite Immunotherapy Drug Helps Blood Cancer Patients in Study
Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Health | Immunotherapy | Lymphoma | Non-Hodgkin's Lymphoma | Pharmaceuticals | Study